Listen to the post-PEGS EU interview of trenzyme’s Director Reinhold Horlacher. We sat down virtually with Reinhold to get to know more about trenzyme’s strategy to support the scientific community in the development of serological tests and in the generation of high-affinity antibodies for novel vaccine candidates.

Reinhold Horlacher PhD

CSO and managing director, trenzyme, Reinhold has a long track record as a protein production and cell line development specialist. With 20 years of expertise, trenzyme is the service provider for highly customized cell line development and recombinant protein production from development to GMP-compliant production. Reinhol’s moto: finding the ideal solution for the individual requirements of trenzymes clients.


A. Nyamay'antu Alengo Nyamay’antu, PhD

Alengo is the Scientific Communication Specialist at Polyplus-transfection. Alengo is a globe trotter specialized in Protein Biochemistry and Biomedecine that is particularly keen on exchanging and discussing Science.

• trenzyme, its know-how and its mission
• Off the shelf recombinant SARS-CoV-2 proteins.
• Overcoming production of spike proteins challenges
• Critical parameters for protein production platform set-up
• XPOVAX, an innovative COVID-19 vaccine strategy


Find trenzyme presentation at PEGS EU 2020 Virtual congress below:

Other sources

Check our FAQs

These FAQs are organized by application to guide you to find the best answer possible.

Product Documents

You have access to all the documents related to the Polyplus Products such as MSDS, NHPS and Posters.

Polyplus-transfection Database

Search for publications in the Transfection Database with Polyplus transfection reagents or for transfection conditions. Over 6000 publications, 1000 cell lines and primary cells available.


This lexicon will help you to understand the different terms related to Polyplus products and services.

Learn more



PEGS Europe

View All Resources